Search

Your search keyword '"Iuliano, Gerardo"' showing total 226 results

Search Constraints

Start Over You searched for: Author "Iuliano, Gerardo" Remove constraint Author: "Iuliano, Gerardo"
226 results on '"Iuliano, Gerardo"'

Search Results

1. Longitudinal modeling of MS patient trajectories improves predictions of disability progression

2. Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study

3. Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression

4. Treatment Response Score to Glatiramer Acetate or Interferon Beta-1a

5. Disability accrual in primary and secondary progressive multiple sclerosis

6. Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis

7. Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis

8. Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis

9. Disability accrual in primary and secondary progressive multiple sclerosis

10. sj-docx-1-msj-10.1177_13524585231151951 – Supplemental material for Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis

12. Machine-learning-based prediction of disability progression in multiple sclerosis: an observational, international, multi-center study

13. Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS

14. Confirmed disability progression as a marker of permanent disability in multiple sclerosis.

15. Confirmed disability progression as a marker of permanent disability in multiple sclerosis

16. Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis

17. sj-docx-1-msj-10.1177_13524585221084577 – Supplemental material for Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS

18. Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study

19. Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS

20. Towards personalized therapy for multiple sclerosis: prediction of individual treatment response

21. Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

22. Corrigendum to Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression: [Computer Methods and Programs in Biomedicine, Volume 208, (September 2021) 106180]

23. Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis

24. Defining reliable disability outcomes in multiple sclerosis

25. Association of Latitude and Exposure to Ultraviolet B Radiation with Severity of Multiple Sclerosis

27. Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial

28. Risk of secondary progressive multiple sclerosis after early worsening of disability

29. Comparison of Switch to Fingolimod or Interferon Beta/Glatiramer Acetate in Active Multiple Sclerosis

30. Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression.

31. sj-pdf-1-msj-10.1177_1352458520981300 – Supplemental material for Determinants of therapeutic lag in multiple sclerosis

32. Seasonal variation of relapse rate in multiple sclerosis is latitude dependent

35. Variability of the Response to Immunotherapy Among Sub-groups of Patients With Multiple Sclerosis (4107)

36. Disability Accrual in Primary Progressive & Secondary Progressive Multiple Sclerosis (2901)

37. Determinants of therapeutic lag in multiple sclerosis

38. Sex as a determinant of relapse incidence and progressive course of multiple sclerosis

39. Identification of Therapeutic Lag in Multiple Sclerosis

40. Immunotherapies Improve Long-Term Disability Outcomes in Relapsing-Remitting Multiple Sclerosis

41. MSJ926955_supplementary_material – Supplemental material for Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis

42. Predicting Long-Term Sustained Disability Progression in Multiple Sclerosis

43. Treatment response score to glatiramer acetate or interferon beta-1a.

44. Risk of secondary progressive multiple sclerosis: A longitudinal study.

45. The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry

46. Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis

48. Identification of Therapeutic Lag in Multiple Sclerosis (1787)

49. Determinants of Therapeutic Lag in Multiple Sclerosis (2059)

Catalog

Books, media, physical & digital resources